Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimewise-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Medwise Overseas Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimewise-M 1 Tablet PR

Diabetol Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for managing type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a quick-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, will be necessary.

Uses of Glimewise-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimewise-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take one Glimewise-M PR tablet with food.

Common Side effects of Glimewise-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimewise-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer one Glimewise-M tablet (PR) with a meal.

How Glimewise-M 1 Tablet PR works:

Glimewise-M PR, a single-tablet formulation, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts triply: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimewise-M 1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimewise-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glimewise-M 1 Tablet PR; evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimewise-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Glimewise-M 1 Tablet PR is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimewise-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate hepatic dysfunction, initiation with a reduced dose is typical; however, Glimewise-M 1 Tablet PR is contraindicated in patients with severe liver disease.

What if you forget to take Glimewise-M 1 Tablet PR :

For a missed Glimewise-M 1 Tablet PR dose, take it promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual medication schedule. Avoid taking a double dose.

Facts to Know About Glimewise-M 1 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimewise-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimewise-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimewise-M 1 Tablet PR and seek immediate medical attention.
Glimewise-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimepiride (Glimewise-M 1 Tablet PR) may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimepiride (Glimewise-M) use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimepiride (Glimewise-M 1 Tablet PR) can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with skipped meals, alcohol consumption, strenuous exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimepiride (Glimewise-M) with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimewise-M 1 Tablet PR
45
MRP 55
18% off